As of June 09, 2026, Corvus Pharmaceuticals's top three insider holders are Peter A. Thompson (Director, 7.17Mn shares), Advisors Llc Orbimed (Director, 7.17Mn shares), Peter A. Thompson (Director, 6.94Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Advisors Llc Orbimed | - | 0 | 7,165,006 | 01 Jul, 2025 |
| Peter A. Thompson | - | 0 | 7,165,006 | 01 Jul, 2025 |
| Capital, Llc Ecor1 | - | 0 | 81,077 | 01 Oct, 2021 |
| William Benton Jones | - | 173,130 | 0 | 06 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 30,000 | $15.00 | 30,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $9.70 | 45,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $12.50 | 60,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $3.61 | 75,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.00 | 90,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $3.27 | 105,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.74 | 120,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.60 | 135,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $0.99 | 150,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $0.97 | 165,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.49 | 180,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $1.64 | 195,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.12 | 210,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 30,000 | $0.00 | 0 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 0 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 0 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 0 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 0 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 0 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 0 | D | M |